Home > Boards > US Listed > Biotechs > Immatics NV (IMTX)

Looks interesting

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Solarfuture Member Profile
 
Followed By 8
Posts 1,107
Boards Moderated 0
Alias Born 07/23/10
160x600 placeholder
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/1/2021 7:32:30 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 3/30/2021 6:20:13 PM
Annual and Transition Report (foreign Private Issuer) (20-f) Edgar (US Regulatory) - 3/30/2021 7:52:55 AM
Immatics beats on revenue Seeking Alpha - 3/30/2021 7:27:51 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/30/2021 7:19:05 AM
Immatics Announces Full Year 2020 Financial Results and Corporate Update GlobeNewswire Inc. - 3/30/2021 7:00:00 AM
Immatics shares jump after early-stage Adoptive Cell Therapy cancer study data Seeking Alpha - 3/17/2021 8:27:58 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 3/17/2021 7:33:42 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/17/2021 7:32:10 AM
Immatics Presents Data Update on Dose Escalation from Ongoing ACTengine® Cell Therapy Programs GlobeNewswire Inc. - 3/17/2021 7:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/16/2021 5:15:21 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/12/2021 1:03:48 PM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 1/6/2021 6:01:57 AM
Immatics Announces Third Quarter 2020 Financial Results and Business Update GlobeNewswire Inc. - 12/2/2020 7:00:00 AM
Immatics Presents Phase I Data from ACTolog® Multi-Target Pilot Study IMA101 at the 35th Annual SITC Conference GlobeNewswire Inc. - 11/10/2020 7:00:00 AM
Immatics Presents Preclinical Proof-of-Concept Data for TCR Bispecifics Program IMA401 Targeting MAGEA4/8 GlobeNewswire Inc. - 10/29/2020 7:00:00 AM
Blockbuster Year and Bright Horizons for SPACs NetworkNewsWire - 10/13/2020 8:45:00 AM
Immatics Appoints Arnd Christ as Chief Financial Officer GlobeNewswire Inc. - 9/29/2020 7:00:00 AM
Immatics Appoints Biotech Executive Eliot Forster to Board of Directors GlobeNewswire Inc. - 9/15/2020 7:00:00 AM
Immatics Provides Update on IMA204 ACTengine® Cell Therapy Program Targeting the Tumor Microenvironment GlobeNewswire Inc. - 9/10/2020 7:00:00 AM
Immatics Announces Second Quarter 2020 Financial Results and Business Update GlobeNewswire Inc. - 9/3/2020 7:00:00 AM
Immatics Announces European Clinical Expansion of its Adoptive Cell Therapy Programs GlobeNewswire Inc. - 8/18/2020 7:00:00 AM
Immatics Extends Cell Therapy Manufacturing Collaboration with UTHealth GlobeNewswire Inc. - 8/6/2020 7:00:00 AM
Immatics Announces Board of Directors Additions Following Public Listing on NASDAQ GlobeNewswire Inc. - 7/9/2020 7:00:00 AM
Immatics Announces Completion of Business Combination and Listing on NASDAQ GlobeNewswire Inc. - 7/2/2020 7:00:00 AM
Solarfuture   Monday, 07/06/20 01:31:46 PM
Re: marketmanallm post# 1
Post # of 19 
Looks interesting

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences